Category Archives: Ophthalmology

Comparison of age-related macular degeneration treatments trials: Lucentis-Avastin trial

January 18th, 2012 - 12:22 pm

Sophie J. Bakri, M.D., with the Department of Ophthalmology at Mayo Clinic in Rochester, Minn., and study principal investigator at Mayo Clinic, discusses first-year results from the National Eye Institute–funded study of neovascular age-related macular degeneration (AMD). Findings indicate that bevacizumab … Continue reading →

By Miriam Wuensch | Posted in Ophthalmology | Tagged , , , , , , , | Leave a comment

E2-2 protein and Fuchs corneal dystrophy

January 25th, 2011 - 11:14 am

Keith H. Baratz, M.D. of the Department of Ophthalmology discusses a genomewide association study that indicates a genetic variation in TCF4 contributes to the development of Fuchs corneal dystrophy (FCD).   ABSTRACT Background Fuchs corneal dystrophy is a leading cause of corneal … Continue reading →

By Miriam Wuensch | Posted in Ophthalmology | Tagged , , , , | Comments (2)

Rituximab in the treatment of Graves’ ophthalmopathy

May 19th, 2010 - 10:12 am

Dr. Marius N. Stan disucssed the use of Rituximab in the treatment of Graves’ Ophthalmopathy. Graves’ ophthalmopathy (GO), the inflammatory eye disease associated with Graves’ hyperthyroidism, is characterized by proptosis, eye pain, periorbital edema, and extraocular muscle dysfunction. The signs and … Continue reading →

By Carol Lammers | Posted in Endocrinology, Ophthalmology | Tagged , , , , , , | Comments (3)